Results for tag: "Mydriasis Drug"

Mydriasis is a type of drug used to treat optical disorders. It is a type of mydriatic drug, which is used to dilate the pupil of the eye. Mydriasis drugs are used to treat a variety of conditions, including glaucoma, cataracts, and retinal detachment. They can also be used to diagnose certain eye diseases, such as macular degeneration. Mydriasis drugs are typically administered as eye drops or injections. The mydriasis drug market is a rapidly growing segment of the optical disorders drugs market. It is driven by the increasing prevalence of eye diseases, the growing demand for better diagnosis and treatment of eye diseases, and the development of new drugs. The market is expected to continue to grow in the coming years, as new drugs are developed and the demand for better diagnosis and treatment of eye diseases increases. Some of the major companies in the mydriasis drug market include Allergan, Bausch + Lomb, Novartis, Pfizer, and Santen Pharmaceuticals. Show Less Read more